UTHR Sale Disclosure
Mahon Paul A · SEC Form 4 · Filed Sep 18, 2026
Sale
Calculated transaction value
$62.6K
Mahon Paul A EVP & General Counsel
UTHR
Transaction date
Sep 17, 2026
Public filing date
Sep 18, 2026
Filing lag
Filed 1 day later
UTHR daily price context
Close on/before transaction
$497.27
Sep 17, 2026
Close before public filing
$497.27
Sep 17, 2026
Return since public filing
-0.53%
Through Sep 18, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 125 shares @ $500.8
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001231589-26-000020
Filing cohort
Transactions in this filing
Showing 9 of 9
Trades
9
Issuers
1
Estimated value
$5.34M
Buys / sales
0 / 7
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| United Therapeutics Corp UTHR | Exercise | Sep 17, 2026 | $1.21M |
| United Therapeutics Corp UTHR | Sale | Sep 17, 2026 | $783.13K |
| United Therapeutics Corp UTHR | Sale | Sep 17, 2026 | $1.43M |
| United Therapeutics Corp UTHR | Sale | Sep 17, 2026 | $696.56K |
| United Therapeutics Corp UTHR | Sale | Sep 17, 2026 | $420.44K |
| United Therapeutics Corp UTHR | Sale | Sep 17, 2026 | $579.71K |
| United Therapeutics Corp UTHR Current | Sale | Sep 17, 2026 | $62.6K |
| United Therapeutics Corp UTHR | Sale | Sep 17, 2026 | $160.51K |
| United Therapeutics Corp UTHR | Exercise | Sep 17, 2026 | $0 |